Measurement of MRP2 Function Using Urinary Coproporphyrins
NCT ID: NCT00746044
Last Updated: 2009-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2008-02-29
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of Urinary Biomarkers for the Diagnosis of Insulin Resistance
NCT04010903
Podocyturia - Predictor of Renal Dysfunction in Fabry Nephropathy
NCT02994303
Efficacy and Utility of Cxbladder Tests in Hematuria Patients
NCT04943380
Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease
NCT01039987
STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA
NCT03988309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Healthy volunteers \>18y, 20 male, 20 female
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 18 y
* Affiliated to an health insurance
Exclusion Criteria
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University Hospital, Tours
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chantal LE GUELLEC
Role: STUDY_DIRECTOR
CHRU TOURS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de TOURS
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHAO07-CLG/COVOL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.